Axonics Inc
(MEX:AXNX)
MXN
1227
0 (0%)
Market Cap: 69.62 Bil
Enterprise Value: 63.46 Bil
PE Ratio: 0
PB Ratio: 5.45
GF Score: 26/100 Axonics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 04:30PM GMT
Release Date Price:
MXN1280
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good afternoon, and thank you for joining us for the third day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Axonics with us today, Ray Cohen, CEO; and Dan Dearen, President and CFO.
And before we begin, I'll run through our disclaimer. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to Morgan Stanley sales representative. And with that, Ray, Dan, thank you for joining us today.
Raymond W. Cohen
Axonics, Inc. - CEO & Director
Thanks for the invite. We appreciate being here.
Questions & Answers
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
And I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot